Aflac (NYSE:AFL – Get Free Report) had its price target lifted by Wells Fargo & Company from $109.00 to $118.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has an “equal weight” rating on the financial services provider’s stock. Wells Fargo & Company‘s price target suggests a potential upside of 3.60% from the company’s current price.
AFL has been the topic of several other reports. Barclays set a $101.00 price target on Aflac and gave the company an “underweight” rating in a research report on Thursday, January 8th. JPMorgan Chase & Co. raised their price objective on Aflac from $101.00 to $105.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Evercore boosted their target price on shares of Aflac from $110.00 to $111.00 and gave the company an “underperform” rating in a report on Friday, November 7th. Morgan Stanley set a $120.00 price target on shares of Aflac in a research note on Monday, December 15th. Finally, Raymond James Financial reissued an “outperform” rating and set a $119.00 price target (up from $110.00) on shares of Aflac in a research report on Tuesday, December 30th. Three equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, Aflac has an average rating of “Hold” and an average price target of $111.73.
View Our Latest Stock Report on AFL
Aflac Trading Up 1.3%
Aflac (NYSE:AFL – Get Free Report) last issued its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $1.57 EPS for the quarter, missing the consensus estimate of $1.69 by ($0.12). Aflac had a return on equity of 14.35% and a net margin of 21.24%.The company had revenue of $4.28 billion during the quarter, compared to analysts’ expectations of $4.45 billion. During the same quarter last year, the business earned $1.57 earnings per share. The business’s quarterly revenue was down 9.6% on a year-over-year basis. Sell-side analysts anticipate that Aflac will post 6.88 EPS for the current year.
Insider Activity
In related news, EVP Steven Kent Beaver sold 7,387 shares of the company’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $113.58, for a total value of $839,015.46. Following the transaction, the executive vice president owned 40,526 shares in the company, valued at $4,602,943.08. The trade was a 15.42% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Over the last ninety days, insiders sold 16,331 shares of company stock valued at $1,817,720. 0.90% of the stock is owned by insiders.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of AFL. Stephens Inc. AR raised its holdings in Aflac by 0.4% in the 4th quarter. Stephens Inc. AR now owns 21,945 shares of the financial services provider’s stock worth $2,420,000 after acquiring an additional 91 shares during the last quarter. Root Financial Partners LLC boosted its stake in Aflac by 4.5% during the 4th quarter. Root Financial Partners LLC now owns 2,119 shares of the financial services provider’s stock valued at $234,000 after purchasing an additional 92 shares during the last quarter. CENTRAL TRUST Co increased its holdings in shares of Aflac by 0.5% in the 4th quarter. CENTRAL TRUST Co now owns 19,088 shares of the financial services provider’s stock worth $2,105,000 after purchasing an additional 95 shares in the last quarter. HBK Sorce Advisory LLC increased its holdings in shares of Aflac by 1.2% in the 4th quarter. HBK Sorce Advisory LLC now owns 7,702 shares of the financial services provider’s stock worth $902,000 after purchasing an additional 95 shares in the last quarter. Finally, Confluence Wealth Services Inc. raised its stake in shares of Aflac by 0.8% in the fourth quarter. Confluence Wealth Services Inc. now owns 11,923 shares of the financial services provider’s stock worth $1,315,000 after purchasing an additional 96 shares during the last quarter. 67.44% of the stock is owned by hedge funds and other institutional investors.
More Aflac News
Here are the key news stories impacting Aflac this week:
- Positive Sentiment: Aflac landed a long-term front-of-jersey sponsorship with the NWSL Atlanta expansion team — a 7-year deal that increases local brand visibility in its Georgia home market and supports consumer awareness for supplemental-insurance products. Article Title
- Positive Sentiment: Two recent articles pitching Aflac as a high-yield/AI beneficiary have likely drawn investor interest into the stock as an income and thematic play (coverage boosting retail demand). Article Title
- Neutral Sentiment: Wells Fargo raised its price target from $109 to $118 while keeping an “equal weight” rating — a modest signal of upside but not a fresh buy recommendation. This provides some analyst support but limited conviction. Article Title
- Neutral Sentiment: Recent media pieces comparing Aflac to peers and asking whether to reassess the name highlight mixed fundamentals vs. valuation — useful for context but not new company-specific catalysts. Article Title
- Negative Sentiment: An Aflac EVP, Steven Kent Beaver, sold 7,387 shares (~$839k) in a disclosed SEC filing; insider selling can be interpreted negatively by some investors even though it doesn’t indicate company-wide distress. Article Title
- Negative Sentiment: Recent Q4 results included an EPS miss and year-over-year revenue decline, reminders of operational/headwind risks that limit upside until growth stabilizes. Article Title
About Aflac
Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.
Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.
Featured Stories
- Five stocks we like better than Aflac
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
